Thalassemia and sickle cell anaemia are common genetic disorders in India. Early testing, prenatal screening, and improved ...

Beta Thalassemia occurs due to a mutation in the beta globin gene, which is essential for production of normal haemoglobin, the protein inside our red blood cells which carries oxygen from the ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Certain genotypes of α-thalassemia present with microcytosis ... of an RBC to be dyed by a variety of laboratory stains Red Blood Cell Indices Series of relationships characterizing erythrocytes ...

On the other hand, India also tops in people with Thalassemia, one of the biggest ... said iron provides Haemoglobin (Hb), a protein in the Red Blood Cells, that carries oxygen from the lung ...

Standard treatment for SCD includes red blood cell transfusions and treatment with hydroxyurea ... are at risk of having a child with a hemoglobin disorder (sickle cell disease or thalassemia), and ...

In April 2025, Kamau Therapeutics announced a study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel ...

Morocco has taken a major step forward in medical genetics with the introduction of Whole Exome Sequencing (WES).

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A new study demonstrates how light-dependent resistors (LDRs) and waveguides enable affordable, real-time optical detection ...